Switching from intravenous to subcutaneous Infliximab in patients with immune mediated diseases in clinical remission

被引：0

作者：

Viazis, N. ^{[1
]}

Karamanakos, A. ^{[2
]}

Mousourakis, K. ^{[3
]}

Christidou, A. ^{[4
]}

Fousekis, F. ^{[5
]}

Mpakogiannis, K. ^{[5
]}

Koukoudis, A. ^{[5
]}

Katsanos, K. ^{[5
]}

Christodoulou, D. ^{[5
]}

Cheila, M. ^{[6
]}

Tzouvala, M. ^{[7
]}

Zacharopoulou, E. ^{[7
]}

Palatianou, M. ^{[7
]}

Giouleme, O. ^{[8
]}

Katsoula, A. ^{[8
]}

Liatsos, C. ^{[9
]}

Kyriakos, N. ^{[9
]}

Zampeli, E. ^{[10
]}

Papathanasiou, E. ^{[10
]}

Theodoropoulou, A. ^{[11
]}

Karmiris, K. ^{[12
]}

Psaroudakis, I ^{[13
]}

Tribonias, G. ^{[14
]}

Gazi, S. ^{[15
]}

Mole, E. ^{[15
]}

Dimitroulas, T. ^{[16
]}

Koutsianas, C. ^{[17
]}

Vasilopoulos, D. ^{[17
]}

Fragoulis, G. ^{[18
]}

Michalakeas, N. ^{[18
]}

Papagoras, C. ^{[19
]}

Panagakis, P. ^{[20
]}

Papoutsaki, M. ^{[20
]}

Chasapi, V ^{[20
]}

Stratigos, A. ^{[20
]}

Katsikas, G. ^{[21
]}

机构：

[1] Evangelismos Gen Hosp, Gastroenterol, Athens, Greece

[2] Evangelismos Med Ctr, Rheumatol, Athens, Greece

[3] Evangelismos, Gastroenterol, Athens, Greece

[4] Evangelismos Med Ctr, Gastroenterol, Athens, Greece

[5] Univ Hosp Ioannina, Gastroenterol, Ioannina, Greece

[6] Gen Hosp Evangelismos, Rheumatol, Athens, Greece

[7] Gen Hosp Nikaia Agios Panteleimon, Gastroenterol, Athens, Greece

[8] Second Propedeut Dept Internal Med Hippokrat, Gastroenterol, Thessaloniki, Greece

[9] 401 Gen Mil Hosp, Gastroenterol, Athens, Greece

[10] Gen Hosp Alexandra, Gastroenterol, Athens, Greece

[11] Gen Hosp Venizeleio, Gastroenterol, Hrakleion, Greece

[12] Gen Hosp Venizeleio, Gastroenterol, Iraklion, Greece

[13] Gen Hosp Venizeleio, Gastroenterol, Herakleiomn, Greece

[14] Erythros Stavros, Gastroenterol, Athens, Greece

[15] Gen Hosp Attica, Rheumatol, Athens, Greece

[16] Gen Hosp Ippokrateio, Rheumatol, Thessaloniki, Greece

[17] Gen Hosp Ippokrateio, Rheumatol, Athens, Greece

[18] Joint Acad Rheumatol Ctr Laiko Gen Hosp, Rheumatol, Athens, Greece

[19] Univ Hosp Alexandroupolis, Rheumatol, Alexandroupolis, Greece

[20] Andreas Syggros Hosp, Dermatol, Athens, Greece

[21] Evangelismos Gen Hosp, Rheumatol, Athens, Greece

来源：

JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷

关键词：

D O I：

10.1093/ecco-jcc/jjae190.1120

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P0946

引用

页码：i1773 / i1773

页数：1

共 50 条

[21] Efficacy and Safety of Switching From Intravenous to Subcutaneous Infliximab for Psoriasis: A Case Series
Larney, Conor
Foley, Peter
Gebauer, Kurt
Daniel, Benjamin S.
AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2024,
[22] Switching from intravenous to subcutaneous infliximab: physicians' practice and patients' satisfaction - Results from a nationwide transectional study
Hupe, M.
Laharie, D.
Wils, P.
Uzzan, M.
Peyrin-Biroulet, L.
Kirchgesner, J.
Atanasiu, C.
Cadiot, G.
Richard, N.
Simon, M.
Caillo, L.
Nancey, S.
de Maissin, A.
Vuitton, L.
Hebuterne, X.
Alric, H.
Coffin, B.
Gellouz, S.
Buisson, A.
GETAID
JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1280 - i1281
[23] The East Kent experience of switching from intravenous infliximab to subcutaneous, benefits to the patients, the service and financial implications
Abreu, B.
Scott, G.
JOURNAL OF CROHNS & COLITIS, 2024, 18 : I2239 - I2239
[24] The persistence of subcutaneous infliximab is equivalent to intravenous form in patients with inflammatory bowel diseases
Bothorel, L.
Laharie, D.
Poullenot, F.
Gohier, E.
Chevrier, C.
Berger, A.
Zerbib, F.
Riviere, P.
JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1490 - I1490
[25] Persistence of subcutaneous infliximab after two years of the switch from intravenous infliximab to subcutaneous infliximab in Inflammatory Bowel Disease patients
Huguet, J. M.
Iborra, M.
Marti, L.
Bosca-Watts, M. M.
Ramirez, J. J.
Ruiz, L.
Sanchis, L.
Garrido, A.
Alemany, G.
Suria, C.
Paredes, J. M.
JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1242 - I1242
[26] Switching from VEDOlizumab intravenous to subcutaneous formulation in ulcerative colitis patients in clinical remission: The SVEDO Study, an IG-IBD study
Ribaldone, Davide Giuseppe
Parisio, Laura
Variola, Angela
Bossa, Fabrizio
Castiglione, Fabiana
Marzo, Manuela
Piazza, Nicole
Aratari, Annalisa
Savarino, Edoardo Vincenzo
Bodini, Giorgia
Mastronardi, Mauro
Micheli, Federica
Mazzuoli, Silvia
Ascolani, Marta
Vigano, Chiara
Cappello, Maria
Bezzio, Cristina
Ciccocioppo, Rachele
Scardino, Giulia
Sarli, Ennio
Pugliese, Daniela
Scaldaferri, Franco
Napolitano, Daniele
Todeschini, Alessia
Geccherle, Andrea
Colaci, Nicoletta
Guerra, Maria
Annese, Monica
Testa, Anna
Caiazzo, Anna
Conforti, Francesco Simone
Festa, Stefano
Lorenzon, Greta
Marra, Antonella
Magiotta, Ambra
Baccini, Flavia
Amato, Arnaldo
Poshnjari, Anxhela
Vernero, Marta
Caprioli, Flavio
Caviglia, Gian Paolo
DIGESTIVE AND LIVER DISEASE, 2024, 56 (01) : 77 - 82
[27] Inflammatory Bowel Disease Patients' Acceptance for Switching from Intravenous Infliximab or Vedolizumab to Subcutaneous Formulation: The Nancy Experience
Remy, Clotilde
Caron, Benedicte
Gouynou, Celia
Haghnejad, Vincent
Jeanbert, Elodie
Netter, Patrick
Danese, Silvio
Peyrin-Biroulet, Laurent
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (24)
[28] Clinical efficacy and durability of subcutaneous infliximab in patients with inflammatory bowel disease after switching from intravenous in a Korean multicenter prospective cohort study
Kim, K.
Hong, S. N.
Kang, S. B.
Lee, K. M.
Koo, J. S.
Jung, Y.
Lee, B. J.
Yoon, H.
Kim, H. W.
Lim, Y. J.
Lee, H. S.
Lee, Y. J.
Lee, J.
Lee, C. K.
Shin, S. Y.
Moon, J. M.
Seo, J.
Choi, C. H.
JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1007 - I1009
[29] CLINICAL EFFICACY AND DURABILITY OF SUBCUTANEOUS INFLIXIMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AFTER SWITCHING FROM INTRAVENOUS INFLIXIMAB: A REAL-WORLD MULTICENTER PROSPECTIVE COHORT STUDY IN KOREA
Kim, Kyuwon
Hong, Sung Noh
Kang, Sang-Bum
Lee, Kang-Moon
Koo, Ja Seol
Jung, Yunho
Lee, Beom Jae
Yoon, Hyuk
Kim, Hyung Wook
Lim, Yun Jeong
Lee, Hyun Seok
Lee, Yoo Jin
Lee, Jun
Lee, Chang Kyun
Moon, Jung Min
Shin, Seung Yong
Seo, Jeongkuk
Choi, Chang Hwan
GASTROENTEROLOGY, 2024, 166 (05) : S1136 - S1136
[30] Effectiveness of Switching to Subcutaneous Infliximab in Pediatric Inflammatory Bowel Disease Patients on Intravenous Maintenance Therapy
Gianolio, Laura
Armstrong, Katherine
Swann, Ewan
Shepherd, Rhona
Henderson, Paul
Wilson, David C. C.
Russell, Richard K. K.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2023, 77 (02): : 235 - 239

← 1 2 3 4 5 →